Overview The Wisconsin Society of Addiction Medicine would like to invite you to view the recordings from the 2020 Virtual Conference Series. The series consisted of three days with 4-5 live sessions available each day.
Mental health and substance use disorders affect people from all walks of life and all age groups. Substance use disorders and behavioral addictions often are a result of self-treatment of underlying and untreated/undertreated mental health conditions. These illnesses are common, recurrent, and often serious, but they are treatable, and many people do recover. The increase demand for treatment, however, is not is not being met by a corresponding increase in access to or availability treatment. Practitioners may not have the clinical skills or knowledge to adequately treat an individual presenting with poly-substance use disorder and co-occurring mental illness. Updated education on treatment options and barriers is needed in order for clinicians to implement effective strategies to the prevention and treatment of addictive disorders.
You are able to register online for one, two or all three days with member and non member pricing. Please complete the registration form and payment. You will receive a confirmation email with the a link to access the recordings.
Friday, September 11 | 12:00-5:00 p.m.
12:00 PM - Neuropharmacology Needed to Mitigate Methamphetamine and Cocaine Addiction in the Absence of FDA Approved Treatments; William
Morrone, DO, MS, MPH, FACOFP, DAAPM, FASAM (Keynote Speaker)
2:00 PM - Update on Cannabis and Cannabis Research; David Galbis-Reig, MD, DFASAM
3:00 PM - Hep C treatment/PREP/ID complications of IVDU; Alison Miller, DO; Jillian Landeck, MD
4:00 PM - Poking Holes in Addiction: The Role of Acupuncture in Treating Substance Abuse Disorder; Steven Mui, Dipl.Ac.
Friday, October 9 | 1:00-5:00 p.m.
1:00 PM - Madison Addiction Recovery Initiative; Joseph Balles, Captain
2:00 PM - Care for Methamphetamine Use in Pregnancy; Charles Schauberger, MD, MS
3:00 PM - Current Research into Psychedelic Therapeutics for Substance Use Disorders and Mental Health Concerns; Randy Brown, MD, PhD, DFASAM
4:00 PM - The Dangers of Vaping: What we know and what we don’t know; Allison Gorrilla and Amy Skora, UW-CTRI
Friday, November 13 | 1:00-5:00 p.m.
1:00 PM - Infectious disease complications of IV drug users; Robert Gullberg, MD
2:00 PM - Addiction: It's not just about substances anymore; Thomas Hayes, PhD; Susan Knower, LPC
3:00 PM - Utility of Dialectical Behavioral Therapy (DBT) in Substance Use Disorders; Lesley Chapin, Psy.D
4:00 PM - Substance Use and the LGBTQ+ Community; Gregory Simons, PhD
*All of the sessions from each day have been recorded and are available to those who have purchased them.
AMA Credit Designation
American Society of Addiction Medicine designates this enduring material for a
maximum of13AMA PRA Category 1 Credit (s)™.Physicians should claim only
the credit commensurate with the extent of their participation in the activity.
activity has been planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for Continuing Medical Education
through the joint providership of The American Society of Addiction Medicine
(ASAM) and the Wisconsin Society of Addiction Medicine (WISAM).
American Society of Addiction Medicine is accredited by the ACCME to provide
continuing medical education for physicians.
If you have any additional questions, please reach out to the WISAM office directly at WISAM@badgerbay.co (not .com) or call us at 920-750-7727.